Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

European early phase II dose-finding study of droloxifene in advanced breast cancer.

European early phase II dose-finding study of droloxifene in advanced breast cancer. Am J Clin Oncol. 1991; 14 Suppl 2:S36-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.